The difference between the absorbable surgical suture industry sizes in the world is estimated to grow by USD 3.8 billion in 2025 and is projected to grow by USD 4.1 billion in 2026 to about USD 7.9 billion by 2035 with a 7.6% CAGR during 2026-2035.
Absorbable Surgical Sutures Market Revenue and Trends
The absorbent sutures market in the world is concentrated on the use of absorbent sutures in wound repair during surgery using biodegradable substances that can be absorbed in the body without the necessity of removal and the possibility of contamination.
The market worldwide is expanding at a high rate in terms of absorbable surgical sutures as a result of the higher volumes of surgical operations and surgical cases, older population, new developments in the suture material, and less invasive procedures in medical institutions across the world.
.png)
What are the Factors That Have a Significant Contribution to the Growth of the absorbable surgical sutures market?
The increased number of patients who undergo surgical procedures to manage chronic diseases like cardiovascular diseases, orthopedic disorders, cancer, and diabetes due to ageing and lifestyle related health problems has increased the demand of absorbable suture products. With increasing cases of surgeries around the world each year, with millions of operations, more patients are gaining out of absorbable sutures that assist in healing processes without any secondary surgery involving the removal of the suture.
Innovations such as the use of antimicrobial-coated sutures, barbed designs, and synthetic polymers with increased tensile and predictable absorption rates have been introduced through technology to enhance the results and compliance of patients. Other reasons are the heightened awareness of infection control, widening of reimbursement of advanced wound closure, and government programs on promotion of minimally invasive surgeries in developed and emerging areas.
Segment Insight
By Product Type
By product, synthetic absorbable sutures controlled as of 2025 by far the biggest portion of the absorbable surgical suture market, catalyzed by the high demand by large portions of the surgery and cardiovascular and orthopedic patient groups of high-quality materials such as polyglycolic acid and polydioxanone in general surgery, cardiovascular, and orthopedic surgery, and further innovation in monofilament and multifilament products continues to be reported by large numbers of surgeons as the most effective available tools to reduce tissue reactivity and enhance recovery.
By Distribution Channel
The biggest market share is concentrated in hospitals and specialty surgical centers, which are major centers of surgery, acquiring advanced sutures, and dealing with complicated wound closure requirements. As these channels are the source of professional knowledge of the procedure-specific choice, sterilization, and support of the patients who have undergone substantial surgeries, they have become the choice for delivering the absorbable sutures.
Regional Insights
The North American marketplace controls the market of absorbable surgical sutures worldwide because it has highly developed healthcare systems, large quantities of surgical operations, and higher usage rates of hi-tech absorbable technologies. Other advantages of North America are sound reimbursement policies, high use of surgical services, and early adoption of antimicrobials as well as barbed suture. The availability of large industry players and continuous development of the products and clinical research underpin the further leading role of North America.
In addition, the Asia Pacific region is reporting the greatest rate of growth in the absorbable surgical sutures market due to the high number and aging number of patients, increase in cases of chronic illnesses, and growth in the healthcare facility. It has been observed that there has been an upward trend in the adoption of absorbable sutures in China, India, and Japan due to the improvement in their affordability, the rise in the awareness of minimally invasive sutures, and the expansion of government funded healthcare programs. The rapid growth of medical tourism, urbanization, and volume of surgery in this region will lead to a quick growth of the market in Asia Pacific.
Report Scope
Feature of the Report | Details |
Market Size in 2026 | USD 4.1 billion |
Projected Market Size in 2035 | USD 7.9 billion |
Market Size in 2025 | USD 3.8 billion |
CAGR Growth Rate | 7.6% CAGR |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Key Segment | By Material Type, Application, End User, Distribution Channel and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Recent Developments
In December 2025: DemeTECH Corporation introduced DemeSorb, a new polydioxanone monofilament absorbable suture featuring improved handling characteristics and enhanced tensile strength for soft-tissue approximation. (Source: DemeTECH)
List of the prominent players in the Absorbable Surgical Sutures Market:
Johnson & Johnson (Ethicon)
Medtronic plc
B. Braun Melsungen AG
Smith & Nephew plc
Boston Scientific Corporation
3M Company
DemeTECH Corporation
Surgical Specialties Corporation
Internacional Farmacéutica S.A. de C.V.
W.L. Gore & Associates
Others
The Absorbable Surgical Sutures Market is segmented as follows:
By Material Type
Natural Absorbable Sutures
o Catgut (Plain)
o Chromic Catgut
o Collagen-based
Synthetic Absorbable Sutures
o Polyglycolic Acid (PGA)
o Polylactic Acid (PLA)
o Polyglactin (Vicryl)
o Polydioxanone (PDS)
o Poliglecaprone (Monocryl)
o Polytrimethylene Carbonate (Maxon)
By Application
Cardiovascular Surgery
General Surgery
o Abdominal Surgery
o Gastrointestinal Surgery
o Hernia Repair
Gynecological Surgery
o Cesarean Section
o Hysterectomy
o Pelvic Floor Repair
Orthopedic Surgery
o Soft Tissue Repair
o Arthroscopic Surgery
o Tendon/Ligament Repair
Ophthalmic Surgery
Cosmetic and Plastic Surgery
o Reconstructive Surgery
o Aesthetic Surgery
Others
o Dental Surgery
o Urological Surgery
o Pediatric Surgery
By End User
Hospitals
o Teaching/Academic Hospitals
o Community Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Distribution Channel
Direct Sales
Medical Distributors
Online Platforms
Regional Coverage:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
Germany
France
U.K.
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Taiwan
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
